Keywords
Last Name
Institution

Michael Domanski

TitlePROFESSOR
InstitutionMount Sinai
DepartmentMedicine
Address5 East 98th Street, 3rd floor
New York Ny 10029
Phone212-241-6196
Fax212-241-8872
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentHealth Evidence and Policy


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JG, Cohn JN, Dickstein K, Domanski MJ, Ekman I, Filippatos GS, Gheorghiade M, Hernandez AF, Jaarsma T, Koglin J, Konstam M, Kupfer S, Maggioni AP, Mebazaa A, Metra M, Nowack C, Pieske B, Piña IL, Pocock SJ, Ponikowski P, Rosano G, Ruilope LM, Ruschitzka F, Severin T, Solomon S, Stein K, Stockbridge NL, Stough WG, Swedberg K, Tavazzi L, Voors AA, Wasserman SM, Woehrle H, Zalewski A, McMurray JJ. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail. 2013 Oct; 15(10):1082-94.
      View in: PubMed
    2. Domanski MJ, Giddens DP. Optimization of pulsatile flow for mechanical circulatory support. J Heart Lung Transplant. 2013 Jun; 32(6):577-8.
      View in: PubMed
    3. Farkouh ME, Boden WE, Bittner V, Muratov V, Hartigan P, Ogdie M, Bertolet M, Mathewkutty S, Teo K, Maron DJ, Sethi SS, Domanski M, Frye RL, Fuster V. Risk factor control for coronary artery disease secondary prevention in large randomized trials. J Am Coll Cardiol. 2013 Apr 16; 61(15):1607-15.
      View in: PubMed
    4. Farkouh ME, Domanski M, Fuster V. Revascularization strategies in patients with diabetes. N Engl J Med. 2013 Apr 11; 368(15):1455-6.
      View in: PubMed
    5. Ahmed H, Miller MA, Dukkipati SR, Cammack S, Koruth JS, Gangireddy S, Ellsworth BA, D'Avila A, Domanski M, Gelijns AC, Moskowitz A, Reddy VY. Adjunctive renal sympathetic denervation to modify hypertension as upstream therapy in the treatment of atrial fibrillation (H-FIB) study: clinical background and study design. J Cardiovasc Electrophysiol. 2013 May; 24(5):503-9.
      View in: PubMed
    6. Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Røsjø H, Šaltyte Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013 Mar 26; 61(12):1240-9.
      View in: PubMed
    7. Mehra MR, Domanski MJ. Should left ventricular assist device should be standard of care for patients with refractory heart failure who are not transplantation candidates?: left ventricular assist devices should be considered standard of care for patients with refractory heart failure who are not transplantation candidates. Circulation. 2012 Dec 18; 126(25):3081-7.
      View in: PubMed
    8. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S, Bertrand M, Fuster V. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012 Dec 20; 367(25):2375-84.
      View in: PubMed
    9. Domanski MJ. Prognostic implications of troponin T and creatine kinase-MB elevation after coronary artery bypass grafting. Am Heart J. 2012 Nov; 164(5):636-7.
      View in: PubMed
    10. Bansilal S, Farkouh ME, Hueb W, Ogdie M, Dangas G, Lansky AJ, Cohen DJ, Magnuson EA, Ramanathan K, Tanguay JF, Muratov V, Sleeper LA, Domanski M, Bertrand ME, Fuster V. The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. Am Heart J. 2012 Oct; 164(4):591-9.
      View in: PubMed
    11. Fleg JL, Stone GW, Fayad ZA, Granada JF, Hatsukami TS, Kolodgie FD, Ohayon J, Pettigrew R, Sabatine MS, Tearney GJ, Waxman S, Domanski MJ, Srinivas PR, Narula J. Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. JACC Cardiovasc Imaging. 2012 Sep; 5(9):941-55.
      View in: PubMed
    12. Lakhanpal JR, Domanski MJ. Hypothesis: Catheter-based renal sympathetic denervation should be the initial therapy for essential hypertension. Med Hypotheses. 2012 Apr; 78(4):482-4.
      View in: PubMed
    13. Mohar DS, Barseghian A, Haider N, Domanski M, Narula J. Atherosclerosis in chronic kidney disease: lessons learned from glycation in diabetes. Med Clin North Am. 2012 Jan; 96(1):57-65.
      View in: PubMed
    14. Kedzierska K, Domanski M, Sporniak-Tutak K, Dolegowska B, Ciechanowski K. Oxidative stress and renal interstitial fibrosis in patients after renal transplantation: current state of knowledge. Transplant Proc. 2011 Dec; 43(10):3577-83.
      View in: PubMed
    15. Domanski M, Lloyd-Jones D, Fuster V, Grundy S. Can we dramatically reduce the incidence of coronary heart disease? Nat Rev Cardiol. 2011 Dec; 8(12):721-5.
      View in: PubMed
    16. Pinney SP, Balakrishnan R, Dikman S, Nair A, Hammond K, Domanski M, Anyanwu AC, Deboccardo G. Histopathology of renal failure after heart transplantation: a diverse spectrum. J Heart Lung Transplant. 2012 Mar; 31(3):233-7.
      View in: PubMed
    17. Vardeny O, Uno H, Braunwald E, Rouleau JL, Gersh B, Maggioni AP, Domanski M, Pfeffer MA, Solomon SD. Opposing effects of ß blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease. Am J Cardiol. 2011 Jun 15; 107(12):1705-9.
      View in: PubMed
    18. Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G, Engoren M, Alexander JH, Levy JH, Chaitman BR, Broderick S, Mack MJ, Pieper KS, Farkouh ME. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA. 2011 Feb 9; 305(6):585-91.
      View in: PubMed
    19. Domanski M, Pocock S, Bernaud C, Borer J, Geller N, Revkin J, Zannad F. Surrogate endpoints in randomized cardiovascular clinical trials. Fundam Clin Pharmacol. 2011 Aug; 25(4):411-3.
      View in: PubMed
    20. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009 Dec 24; 361(26):2538-47.
      View in: PubMed
    21. Domanski M, Tian X, Fleg J, Coady S, Gosen C, Kirby R, Sachdev V, Knatterud G, Braunwald E. Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial. Am J Cardiol. 2008 Oct 15; 102(8):1023-7.
      View in: PubMed
    22. Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol. 2008 Jul; 19(7):720-4.
      View in: PubMed
    23. Hsia J, Jablonski KA, Rice MM, Sabatine MS, Zabalgoitia M, Maggioni A, Cuddy TE, Domanski MJ, Geller NL, Flaker G, Solomon S, Omland T, Rouleau JL. Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function. Am J Cardiol. 2008 Feb 15; 101(4):457-61.
      View in: PubMed
    24. Farkouh ME, Dangas G, Leon MB, Smith C, Nesto R, Buse JB, Cohen DJ, Mahoney E, Sleeper L, King S, Domanski M, McKinlay S, Fuster V. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J. 2008 Feb; 155(2):215-23.
      View in: PubMed
    25. Solomon SD, Lin J, Solomon CG, Jablonski KA, Rice MM, Steffes M, Domanski M, Hsia J, Gersh BJ, Arnold JM, Rouleau J, Braunwald E, Pfeffer MA. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation. 2007 Dec 4; 116(23):2687-93.
      View in: PubMed
    26. Domanski MJ. Primary prevention of coronary artery disease. N Engl J Med. 2007 Oct 11; 357(15):1543-5.
      View in: PubMed
    27. Sabatine MS, Morrow DA, O'Donoghue M, Jablonksi KA, Rice MM, Solomon S, Rosenberg Y, Domanski MJ, Hsia J. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease. Arterioscler Thromb Vasc Biol. 2007 Nov; 27(11):2463-9.
      View in: PubMed
    28. Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol. 2007 Jul 17; 50(3):205-14.
      View in: PubMed
    29. Olshansky B, Wood F, Hellkamp AS, Poole JE, Anderson J, Johnson GW, Boineau R, Domanski MJ, Mark DB, Lee KL, Bardy GH. Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J. 2007 Jun; 153(6):1089-94.
      View in: PubMed
    30. Sanders GD, Al-Khatib SM, Berliner E, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis AB, Curtis JP, Domanski M, Fain E, Gersh BJ, Gold MR, Goldberger J, Haghighi-Mood A, Hammill SC, Harder J, Healey J, Hlatky MA, Hohnloser SH, Lee KL, Mark DB, Mitchell B, Phurrough S, Prystowsky E, Smith JM, Stockbridge N, Temple R. Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. Am Heart J. 2007 Jun; 153(6):951-9.
      View in: PubMed
    31. Mitchell GF, Dunlap ME, Warnica W, Ducharme A, Arnold JM, Tardif JC, Solomon SD, Domanski MJ, Jablonski KA, Rice MM, Pfeffer MA. Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension. 2007 Jun; 49(6):1271-7.
      View in: PubMed
    32. Bonds DE, Kurashige EM, Bergenstal R, Brillon D, Domanski M, Felicetta JV, Fonseca VA, Hall K, Hramiak I, Miller ME, Osei K, Simons-Morton DG. Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007 Jun 18; 99(12A):80i-89i.
      View in: PubMed
    33. Chew EY, Ambrosius WT, Howard LT, Greven CM, Johnson S, Danis RP, Davis MD, Genuth S, Domanski M. Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE). Am J Cardiol. 2007 Jun 18; 99(12A):103i-111i.
      View in: PubMed
    34. Domanski M, Coady S, Fleg J, Tian X, Sachdev V. Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]). Am J Cardiol. 2007 May 15; 99(10):1448-50.
      View in: PubMed
    35. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation. 2007 Mar 27; 115(12):1528-36.
      View in: PubMed
    36. Liggett SB, Mialet-Perez J, Thaneemit-Chen S, Weber SA, Greene SM, Hodne D, Nelson B, Morrison J, Domanski MJ, Wagoner LE, Abraham WT, Anderson JL, Carlquist JF, Krause-Steinrauf HJ, Lazzeroni LC, Port JD, Lavori PW, Bristow MR. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci U S A. 2006 Jul 25; 103(30):11288-93.
      View in: PubMed
    37. Domanski MJ, Nanda N. Echocardiographic determination of left ventricular function. J Am Soc Echocardiogr. 2006 Jul; 19(7):941-2.
      View in: PubMed
    38. Mirkhel A, Peyster E, Sundeen J, Greene L, Michelson AD, Hasan A, Domanski M. Frequency of aspirin resistance in a community hospital. Am J Cardiol. 2006 Sep 1; 98(5):577-9.
      View in: PubMed
    39. Solomon SD, Rice MM, A Jablonski K, Jose P, Domanski M, Sabatine M, Gersh BJ, Rouleau J, Pfeffer MA, Braunwald E. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation. 2006 Jul 4; 114(1):26-31.
      View in: PubMed
    40. Domanski M, Tian X, Haigney M, Pitt B. Diuretic use, progressive heart failure, and death in patients in the DIG study. J Card Fail. 2006 Jun; 12(5):327-32.
      View in: PubMed
    41. Domanski MJ, Jablonski KA, Rice MM, Fowler SE, Braunwald E. Obesity and cardiovascular events in patients with established coronary disease. Eur Heart J. 2006 Jun; 27(12):1416-22.
      View in: PubMed
    42. Domanski M, Waldo AL. Catheter ablation of atrial fibrillation: a treatment frontier. J Interv Card Electrophysiol. 2006 Apr; 15(3):141-3.
      View in: PubMed
    43. Domanski M. Prognosis in atrial fibrillation. Eur Heart J. 2006 Apr; 27(8):895-6.
      View in: PubMed
    44. Domanski L, Safranow K, Dolegowska B, Rózanski J, Myslak M, Ciechanowski K, Jakubowska K, Dziedziejko V, Romanowski M, Sulikowski T, Sienko J, Kaminski M, Ostrowski M, Domanski M, Pawlik A, Rac ME, Chlubek D. Hypoxanthine as a graft ischemia marker stimulates catalase activity in the renal vein during reperfusion in humans. Transplant Proc. 2006 Jan-Feb; 38(1):35-8.
      View in: PubMed
    45. Domanski L, Dolegowska B, Safranow K, Rózanski J, Myslak M, Romanowski M, Sienko J, Sulikowski T, Ostrowski M, Kedzierska K, Domanski M, Chlubek D, Pawlik A, Ciechanowski K. Activity of CuZn-superoxide dismutase, catalase and glutathione peroxidase in erythrocytes in kidney allografts during reperfusion in patients with and without delayed graft function. Clin Transplant. 2006 Jan-Feb; 20(1):67-71.
      View in: PubMed
    46. Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005 Apr; 149(4):645-9.
      View in: PubMed
    47. Domanski M, Fleg J, Bristow M, Knox S. The effect of gender on outcome in digitalis-treated heart failure patients. J Card Fail. 2005 Mar; 11(2):83-6.
      View in: PubMed
    48. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005 Jan 20; 352(3):225-37.
      View in: PubMed
    49. Domanski M, Antman EM, McKinlay S, Varshavsky S, Platonov P, Assmann SF, Norman J. Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction. Control Clin Trials. 2004 Dec; 25(6):553-62.
      View in: PubMed
    50. Cooper HA, Domanski MJ, Rosenberg Y, Norman J, Scott JH, Assmann SF, McKinlay SM, Hochman JS, Antman EM. Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial. Am Heart J. 2004 Dec; 148(6):1012-9.
      View in: PubMed
    51. Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med. 2004 Nov 11; 351(20):2058-68.
      View in: PubMed
    52. Bristow MR, Krause-Steinrauf H, Nuzzo R, Liang CS, Lindenfeld J, Lowes BD, Hattler B, Abraham WT, Olson L, Krueger S, Thaneemit-Chen S, Hare JM, Loeb HS, Domanski MJ, Eichhorn EJ, Zelis R, Lavori P. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial. Circulation. 2004 Sep 14; 110(11):1437-42.
      View in: PubMed
    53. Domanski M, Proschan M. The metabolic syndrome. J Am Coll Cardiol. 2004 Apr 21; 43(8):1396-8.
      View in: PubMed
    54. Domanski M, Hertzog M, Coutant J, Gutsche-Perelroizen I, Bontems F, Carlier MF, Guittet E, van Heijenoort C. Coupling of folding and binding of thymosin beta4 upon interaction with monomeric actin monitored by nuclear magnetic resonance. J Biol Chem. 2004 May 28; 279(22):23637-45.
      View in: PubMed
    55. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004 Mar 30; 109(12):1509-13.
      View in: PubMed
    56. Peyster E, Norman J, Domanski M. Prevalence and predictors of heart failure with preserved systolic function: community hospital admissions of a racially and gender diverse elderly population. J Card Fail. 2004 Feb; 10(1):49-54.
      View in: PubMed
    57. Schron EB, Domanski MJ. Implantable devices benefit patients with cardiovascular diseases. J Cardiovasc Nurs. 2003 Nov-Dec; 18(5):337-42.
      View in: PubMed
    58. Domanski MJ, Krause-Steinrauf H, Massie BM, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail. 2003 Oct; 9(5):354-63.
      View in: PubMed
    59. Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol. 2003 Sep 3; 42(5):914-22.
      View in: PubMed
    60. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 2003 Aug 20; 42(4):705-8.
      View in: PubMed
    61. Anderson JL, Krause-Steinrauf H, Goldman S, Clemson BS, Domanski MJ, Hager WD, Murray DR, Mann DL, Massie BM, McNamara DM, Oren R, Rogers WJ. Failure of benefit and early hazard of bucindolol for Class IV heart failure. J Card Fail. 2003 Aug; 9(4):266-77.
      View in: PubMed
    62. Knatterud GL, White C, Geller NL, Campeau L, Forman SA, Domanski M, Forrester JS, Gobel FL, Herd JA, Hickey A, Hoogwerf BJ, Hunninghake DB, Terrin ML, Rosenberg Y. Angiographic changes in saphenous vein grafts are predictors of clinical outcomes. Am Heart J. 2003 Feb; 145(2):262-9.
      View in: PubMed
    63. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002 Dec 5; 347(23):1825-33.
      View in: PubMed
    64. Domanski MJ, Epstein A, Hallstrom A, Saksena S, Zipes DP. Survival of antiarrhythmic or implantable cardioverter defibrillator treated patients with varying degrees of left ventricular dysfunction who survived malignant ventricular arrhythmias. J Cardiovasc Electrophysiol. 2002 Jun; 13(6):580-3.
      View in: PubMed
    65. Domanski M, Mitchell G, Pfeffer M, Neaton JD, Norman J, Svendsen K, Grimm R, Cohen J, Stamler J. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 2002 May 22-29; 287(20):2677-83.
      View in: PubMed
    66. Domanski M, Norman J, Wolz M, Mitchell G, Pfeffer M. Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension. 2001 Oct; 38(4):793-7.
      View in: PubMed
    67. Steinberg JS, Martins J, Sadanandan S, Goldner B, Menchavez E, Domanski M, Russo A, Tullo N, Hallstrom A. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study. Am Heart J. 2001 Sep; 142(3):520-9.
      View in: PubMed
    68. Saksena S, Domanski MJ, Benjamin EJ, Camm AJ, Ezekowitz MD, Gersh BJ, Jalife J, Naccarelli GV, Vlietstra RE, Wyse DG. Report of the NASPE/NHLBI round table on future research directions in atrial fibrillation. Pacing Clin Electrophysiol. 2001 Sep; 24(9 Pt 1):1435-51.
      View in: PubMed
    69. Saskena S, Domanski MJ, Benjamin EJ, Camm AJ, Ezekowitz MD, Gersh BJ, Jalife J, Naccarelli GV, Vlietstra RE, Wyse DG. Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology. J Interv Card Electrophysiol. 2001 Sep; 5(3):345-64.
      View in: PubMed
    70. Pfeffer MA, Domanski M, Verter J, Dunlap M, Flaker GC, Gersh B, Hsia J, Goldberg AD, Limacher MC, Maggioni AP, Rosenberg Y, Rouleau JL, Warnica JW, Wasserman AG, Braunwald E. The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) Trial. Am Heart J. 2001 Sep; 142(3):375-7.
      View in: PubMed
    71. Exner DV, Dries DL, Domanski MJ, Cohn JN. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med. 2001 May 3; 344(18):1351-7.
      View in: PubMed
    72. Domanski MJ, Zipes DP, Benditt DG, Camm AJ, Exner DV, Ezekowitz MD, Greene HL, Lesh MD, Miller JM, Pratt CM, Saksena S, Scheinman MM, Singh BN, Tracy CM, Waldo AL. Central clinical research issues in electrophysiology: report of the NASPE Committee. Pacing Clin Electrophysiol. 2001 Apr; 24(4 Pt 1):526-34.
      View in: PubMed
    73. Domanski MJ, Sutton-Tyrrell K, Mitchell GF, Faxon DP, Pitt B, Sopko G. Determinants and prognostic information provided by pulse pressure in patients with coronary artery disease undergoing revascularization. The Balloon Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 2001 Mar 15; 87(6):675-9.
      View in: PubMed
    74. White CW, Campeau L, Canner P, Domanski M, Forrester JS, Gobel FL, Herd JA, Hoogwerf BJ, Hunninghake DB, Knatterud GL, LoPresti F. Lessons from the post coronary artery bypass graft study in evaluating and controlling technical variability in angiographic trials. Post CABG Investigators. Am J Cardiol. 2001 Jan 1; 87(1):40-3.
      View in: PubMed
    75. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Eur Heart J. 2000 Dec; 21(24):2071-8.
      View in: PubMed
    76. Domanski MJ, Borkowf CB, Campeau L, Knatterud GL, White C, Hoogwerf B, Rosenberg Y, Geller NL. Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators. J Am Coll Cardiol. 2000 Nov 15; 36(6):1877-83.
      View in: PubMed
    77. Domanski MJ. Prevention of sudden cardiac death: management considerations. Curr Opin Cardiol. 2000 Jul; 15(4):304-8.
      View in: PubMed
    78. Shawl F, Kadro W, Domanski MJ, Lapetina FL, Iqbal AA, Dougherty KG, Weisher DD, Marquez JF, Shahab ST. Safety and efficacy of elective carotid artery stenting in high-risk patients. J Am Coll Cardiol. 2000 Jun; 35(7):1721-8.
      View in: PubMed
    79. Cooper HA, Exner DV, Domanski MJ. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000 Jun; 35(7):1753-9.
      View in: PubMed
    80. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000 Mar 1; 35(3):681-9.
      View in: PubMed
    81. McAreavey D, Exner DV, Curtin EL, Domanski MJ. beta-blockers in heart failure: recently completed and ongoing clinical trials. Expert Opin Investig Drugs. 2000 Feb; 9(2):415-28.
      View in: PubMed
    82. Domanski MJ, Sakseena S, Epstein AE, Hallstrom AP, Brodsky MA, Kim S, Lancaster S, Schron E. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol. 1999 Oct; 34(4):1090-5.
      View in: PubMed
    83. Alaupovic P, Fesmire JD, Hunnighake D, Domanski M, Forman S, Knatterud GL, Forrester J, Herd JA, Hoogwerf B, Campeau L, Gobel FL. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial. Atherosclerosis. 1999 Oct; 146(2):369-79.
      View in: PubMed
    84. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation. 1999 Sep 21; 100(12):1311-5.
      View in: PubMed
    85. Domanski MJ, Davis BR, Pfeffer MA, Kastantin M, Mitchell GF. Isolated systolic hypertension : prognostic information provided by pulse pressure. Hypertension. 1999 Sep; 34(3):375-80.
      View in: PubMed
    86. Cooper HA, Exner DV, Waclawiw MA, Domanski MJ. White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]) Am J Cardiol. 1999 Aug 1; 84(3):252-7.
      View in: PubMed
    87. Rashid H, Exner DV, Mirsky I, Cooper HA, Waclawiw MA, Domanski MJ. Comparison of echocardiography and radionuclide angiography as predictors of mortality in patients with left ventricular dysfunction (studies of left ventricular dysfunction). Am J Cardiol. 1999 Aug 1; 84(3):299-303.
      View in: PubMed
    88. Campeau L, Hunninghake DB, Knatterud GL, White CW, Domanski M, Forman SA, Forrester JS, Geller NL, Gobel FL, Herd JA, Hoogwerf BJ, Rosenberg Y. Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators. Circulation. 1999 Jun 29; 99(25):3241-7.
      View in: PubMed
    89. Hoogwerf BJ, Waness A, Cressman M, Canner J, Campeau L, Domanski M, Geller N, Herd A, Hickey A, Hunninghake DB, Knatterud GL, White C. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes. 1999 Jun; 48(6):1289-94.
      View in: PubMed
    90. Exner DV, Dries DL, Waclawiw MA, Shelton B, Domanski MJ. Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1999 Mar 15; 33(4):916-23.
      View in: PubMed
    91. Domanski MJ, Mitchell GF, Norman JE, Exner DV, Pitt B, Pfeffer MA. Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol. 1999 Mar 15; 33(4):951-8.
      View in: PubMed
    92. Domanski MJ, Exner DV, Borkowf CB, Geller NL, Rosenberg Y, Pfeffer MA. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1999 Mar; 33(3):598-604.
      View in: PubMed
    93. Dries DL, Exner DV, Gersh BJ, Cooper HA, Carson PE, Domanski MJ. Racial differences in the outcome of left ventricular dysfunction. N Engl J Med. 1999 Feb 25; 340(8):609-16.
      View in: PubMed
    94. Shawl FA, Domanski MJ, Kaul U, Dougherty KG, Hoff S, Rigali GE, Cornell SL, Shahab ST. Procedural results and early clinical outcome of percutaneous transluminal myocardial revascularization. Am J Cardiol. 1999 Feb 15; 83(4):498-501.
      View in: PubMed
    95. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998 Sep; 32(3):695-703.
      View in: PubMed
    96. Pfeffer MA, Domanski M, Rosenberg Y, Verter J, Geller N, Albert P, Hsia J, Braunwald E. Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design). Prevention of Events with Angiotensin-Converting Enzyme Inhibition. Am J Cardiol. 1998 Aug 6; 82(3A):25H-30H.
      View in: PubMed
    97. Haddy TB, Adde MA, McCalla J, Domanski MJ, Datiles M, Meehan SC, Pikus A, Shad AT, Valdez I, Lopez Vivino L, Magrath IT. Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas. J Clin Oncol. 1998 Jun; 16(6):2070-9.
      View in: PubMed
    98. Domanski MJ, Exner DV. Prevention of sudden cardiac death: a current perspective. J Electrocardiol. 1998; 31 Suppl:47-53.
      View in: PubMed
    99. Campeau L, Knatterud G, Hunninghake B, Domanski M. Optimizing cholesterol lowering therapy: contribution of the Post Coronary Artery Bypass Graft Trial. Eur Heart J. 1997 Nov; 18(11):1683-5.
      View in: PubMed
    100. Domanski MJ, Saksena S, Wyse G, Hallstrom A, Schron EB, Nanda A, Nanda A, Kutalek S. Clinical and socioeconomic profile of patients with malignant ventricular arrhythmias in 1993 to 1995. AVID investigators. Antiarrhythmics Versus Implantable Defibrillator. Am J Cardiol. 1997 Aug 1; 80(3):299-301.
      View in: PubMed
    101. Domanski MJ, Zipes DP, Schron E. Treatment of sudden cardiac death. Current understandings from randomized trials and future research directions. Circulation. 1997 Jun 17; 95(12):2694-9.
      View in: PubMed
    102. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol. 1997 Apr; 29(5):1074-80.
      View in: PubMed
    103. Dries DL, Domanski MJ, Waclawiw MA, Gersh BJ. Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure. Am J Cardiol. 1997 Apr 1; 79(7):909-13.
      View in: PubMed
    104. Domanski M, Solomon A, Gersh B. Developing a paradigm for training cardiovascular clinical investigators. Am J Cardiol. 1996 Oct 15; 78(8):943-4.
      View in: PubMed
    105. Domanski MJ, Sloas MM, Follmann DA, Scalise PP, Tucker EE, Egan D, Pizzo PA. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr. 1995 Jul; 127(1):137-46.
      View in: PubMed
    106. Domanski M, Ellis S, Eagle K. Does preoperative coronary revascularization before noncardiac surgery reduce the risk of coronary events in patients with known coronary artery disease? Am J Cardiol. 1995 Apr 15; 75(12):829-31.
      View in: PubMed
    107. Saksena S, Epstein AE, Lazzara R, Maloney JD, Zipes DP, Benditt DG, Camm AJ, Domanski MJ, Fisher JD, Gersh BJ, et al. Clinical investigation of antiarrhythmic devices. A statement for healthcare professionals from a joint task force of the North American Society of Pacing and Electrophysiology, the American College of Cardiology, the American Heart Association, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology. J Am Coll Cardiol. 1995 Apr; 25(5):961-73.
      View in: PubMed
    108. Saksena S, Epstein AE, Lazzara R, Maloney JD, Zipes DP, Benditt DG, Camm AJ, Domanski MJ, Fisher JD, Gersh BJ, et al. Clinical investigation of antiarrhythmic devices. A statement for healthcare professionals from a joint task force of the American Heart Association, the North American Society of Pacing and Electrophysiology, the American College of Cardiology, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology. Circulation. 1995 Apr 1; 91(7):2097-109.
      View in: PubMed
    109. Saksena S, Epstein AE, Lazzara R, Maloney JD, Zipes DP, Benditt DG, Camm AJ, Domanski MJ, Fisher JD, Gersh BJ, et al. NASPE/ACC/AHA/ESC medical/scientific statement special report--clinical investigation of antiarrhythmic devices: a statement for healthcare professionals from a Joint Task Force of the North American Society of Pacing and Electrophysiology, the American College of Cardiology, the American Heart Association, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology. Pacing Clin Electrophysiol. 1995 Apr; 18(4 Pt 1):637-54.
      View in: PubMed
    110. Saksena S, Epstein AE, Lazzara R, Maloney JD, Zipes DP, Benditt DG, Camm AJ, Domanski MJ, Fisher JD, Gersh BJ, et al. Clinical investigation of antiarrhythmic devices. A statement for healthcare professionals from a joint task force of the North American Society of Pacing and Electrophysiology, the American College of Cardiology, the American Heart Association, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology. Eur Heart J. 1995 Apr; 16(4):446-59.
      View in: PubMed
    111. Hallstrom AP, Greene HL, Wyse DG, Zipes D, Epstein AE, Domanski MJ, Schron EB. Antiarrhythmics Versus Implantable Defibrillators (AVID)--rationale, design, and methods. Am J Cardiol. 1995 Mar 1; 75(7):470-5.
      View in: PubMed
    112. Domanski MJ. Sudden cardiac death prevention: antiarrhythmic drugs and the implantable cardioverter-defibrillator. J Interv Cardiol. 1995 Feb; 8(1):9-15.
      View in: PubMed
    113. Domanski MJ. The epidemiology of atrial fibrillation. Coron Artery Dis. 1995 Feb; 6(2):95-100.
      View in: PubMed
    114. Pennington DG, Griffith BP, McKinlay SM, Oyer PE, Domanski MJ, Portner PM, Watson JT. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Study overview. LVAS Study Group. Left Ventricular Assist System. ASAIO J. 1995 Jan-Mar; 41(1):11-5.
      View in: PubMed
    115. Pennington DG, Griffith BP, Swartz MT, McKinlay SM, Portner PM, Domanski MJ, Watson JT. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Patient selection. LVAS Study Group. Left Ventricular Assist System. ASAIO J. 1995 Jan-Mar; 41(1):23-6.
      View in: PubMed
    116. Domanski MJ, Topol EJ. Cardiogenic shock: current understandings and future research directions. Am J Cardiol. 1994 Oct 1; 74(7):724-6.
      View in: PubMed
    117. Domanski MJ, Friedman LM. Relative role of meta-analysis and randomized controlled trials in the assessment of medical therapies. Am J Cardiol. 1994 Aug 15; 74(4):395-6.
      View in: PubMed
    118. Domanski MJ, Eichhorn EJ. Beta blockade in congestive heart failure--the need for a definitive study. Am J Cardiol. 1994 Mar 15; 73(8):597-9.
      View in: PubMed
    119. Domanski MJ, Buxton AE. The primary prevention of sudden death in patients with coronary artery disease. Ann Intern Med. 1993 Dec 15; 119(12):1218-20.
      View in: PubMed
    120. Domanski MJ, Saksena S. Evaluation of treatment strategies of malignant ventricular tachyarrhythmias in the era of the implantable defibrillator. Am J Cardiol. 1993 Aug 15; 72(5):455-7.
      View in: PubMed
    121. Domanski MJ, Cunnion RE, Fernicola DJ, Roberts WC. Fatal cor pulmonale caused by extensive tumor emboli in the small pulmonary arteries without emboli in the major pulmonary arteries or metastases in the pulmonary parenchyma. Am J Cardiol. 1993 Jul 15; 72(2):233-4.
      View in: PubMed
    122. Domanski MJ, Cunnion RE, Roberts WC. Analysis of fractional area change at various levels in the normal left ventricle. Am J Cardiol. 1992 Nov 15; 70(15):1367-8.
      View in: PubMed
    123. Johnston PG, Lee J, Domanski M, Dressler F, Tucker E, Rothenberg M, Cunnion RE, Pizzo PA, Walsh TJ. Late recurrent Candida endocarditis. Chest. 1991 Jun; 99(6):1531-3.
      View in: PubMed
    124. Domanski MJ, Cunnion RE, Roberts WC. Usefulness of the subaortic diameter for normalizing left ventricular and left atrial dimensions. Am J Cardiol. 1991 Apr 1; 67(8):785-6.
      View in: PubMed
    125. Domanski MJ, Delaney TF, Kleiner DE, Goswitz M, Agatston A, Tucker E, Johnson M, Roberts WC. Primary sarcoma of the heart causing mitral stenosis. Am J Cardiol. 1990 Oct 1; 66(10):893-5.
      View in: PubMed
    126. Shawl FA, Domanski MJ, Yackee JM, Wish MH, Dullum M, Neimat S. Left ventricular rupture complicating percutaneous mitral commissurotomy: salvage using percutaneous cardiopulmonary bypass support. Cathet Cardiovasc Diagn. 1990 Sep; 21(1):26-7.
      View in: PubMed
    127. Shawl FA, Domanski MJ, Wish MH, Davis M. Percutaneous cardiopulmonary bypass support in the catheterization laboratory: technique and complications. Am Heart J. 1990 Jul; 120(1):195-203.
      View in: PubMed
    128. Watson JT, Domanski MJ, Lenfant C. Perspectives on long term mechanical circulatory support for the failing heart. Ann Chir. 1990; 44(2):163-7.
      View in: PubMed
    129. Shawl FA, Domanski MJ, Wish MH, Davis M, Punja S, Hernandez TJ. Emergency cardiopulmonary bypass support in patients with cardiac arrest in the catheterization laboratory. Cathet Cardiovasc Diagn. 1990 Jan; 19(1):8-12.
      View in: PubMed
    130. Shawl FA, Domanski MJ, Punja S, Hernandez TJ. Percutaneous cardiopulmonary bypass support in high-risk patients undergoing percutaneous transluminal coronary angioplasty. Am J Cardiol. 1989 Dec 1; 64(19):1258-63.
      View in: PubMed
    131. Shawl FA, Domanski MJ, Hernandez TJ, Punja S. Emergency percutaneous cardiopulmonary bypass support in cardiogenic shock from acute myocardial infarction. Am J Cardiol. 1989 Nov 1; 64(16):967-70.
      View in: PubMed
    132. Kronenberg MW, Price RR, Smith CW, Robertson RM, Perry JM, Pickens DR, Domanski MJ, Partain CL, Friesinger GC. Evaluation of left ventricular performance using digital subtraction angiography. Am J Cardiol. 1983 Mar 1; 51(5):837-42.
      View in: PubMed
    133. Domanski MJ. A potential clinical application of the end systolic pressure volume relationship to the treatment of heart failure. Med Hypotheses. 1981 Oct; 7(10):1223-9.
      View in: PubMed
    Domanski's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067